Eurosurveillance: Most Recent Articles

In early 2026 in Croatia, a male heterosexual patient of Croatian origin was diagnosed with extensively drug-resistant (XDR) gonorrhoea after unprotected vaginal intercourse with a Croatian female. The Neisseria gonorrhoeae HR027 isolate (genomic lineage B, MLST sequence type (ST)9903) exhibited high-level azithromycin, ceftriaxone, cefixime, benzylpenicillin, ciprofloxacin a...

Over the last decade, bacterial sexually transmitted infection notifications have increased across the European Union/European Economic Area (EU/EEA) and England. However, six EU/EEA countries — Denmark, Finland, Ireland, the Netherlands, Norway and Sweden — and England, reported declines in chlamydia notifications from 2023 to 2024. To explore potential drivers of these decr...

There remains uncertainty whether global influenza seasonality, viral dynamics and epidemic duration have re-established after 2021.

We describe global circulation patterns of influenza viruses from 2021 to 2025 and discuss implications for prevention and surveillance.

We analysed World Health Organization (WHO) FluNet sentinel and ...

Pneumococcal vaccination has been recommended in Germany for adults aged ≥ 60 years (1998) and children aged < 2 years (2006), resulting in a reduction of pneumococcal disease incidence in vaccinated children and unvaccinated individuals through herd protection.

We aimed to investigate serotype distribution of invasive pneumococcal disease (IPD) am...

Understanding population immunity to emerging viruses is critical for risk assessment. We characterised antibody responses to avian influenza A(H9N2) viruses in 298 human sera from adults in New York City. We observed widespread cross-reactive H9-binding antibodies, albeit at lower levels (GMT = 371.3) than against seasonal H3 (GMT = 1,398.0), with low to undetectable haemagg...